The FDA has granted ATS Medical Inc. approval to begin marketing additional sizes of its line of ATS Open Pivot Mechanical Heart Valves, as the company expands its valve product offerings in the U.S. market.
The company has now added 25- and 35-mm mitral valves to its line of U.S. products.
If you enjoy this content, please share it with a colleague
FDA Gives ATS Go Ahead to Market Heart Valves
Related Content
March 20, 2024 — PECA Labs, a medical device company reimagining the field of vascular grafts and valves with durable ...
February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center ...
The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first ...
January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under ...
January 11, 2024 — Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the publication ...
December 20, 2023 — The Smidt Heart Institute at Cedars-Sinai has opened an Aortic Surveillance Clinic for the ...
December 18, 2023 — The Department of Cardiovascular Surgery at The Mount Sinai Hospital has received the highest ...
November 2, 2023 — The University of Maryland Medical Center (UMMC) released a statement on the passing of a patient ...
October 25, 2023 — Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of ...
October 18, 2023 — A study published in The Annals of Thoracic Surgery demonstrates outstanding long-term survival ...